India to Netherlands: Allopurinol Export Trade Route
India has recorded 21 verified shipments of Allopurinol exported to Netherlands, representing a combined trade value of $2.0M USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $96.8K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED, which accounts for 97% of total export value with 15 shipments worth $2.0M USD. On the buying side, NA is the largest importer in Netherlands with $1.9M USD in purchases. The top 3 suppliers — IPCA LABORATORIES LIMITED, INTAS PHARMACEUTICALS LTD, INTAS PHARMACEUTICALS LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Netherlands Allopurinol corridor is one of India's established pharmaceutical export routes, with 21 shipments documented worth a combined $2.0M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's allopurinol manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $96.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with allopurinol's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 9.4%, placing it at rank #14 among India's top allopurinol export destinations globally.
On the import side, key buyers of Indian allopurinol in Netherlands include NA, ACCORD HEALTHCARE B V, IMRES and 4 others. NA is the single largest importer with 12 shipments valued at $1.9M USD.
